×
ADVERTISEMENT

at-risk adolescents

FDA Expands Indication for Truvada for PrEP Among Adolescents

The FDA granted a new indication for Gilead's Truvada to reduce the risk for sexually acquired HIV-1 in at-risk ...

MAY 15, 2018

Load more